MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders

Neurology

Volumn 51, Issue 1, 1998, Pages 26-32

  Martinez, Manuela ^a   Vazquez, Elida ^a  

^a Ctr Res Biochem and Molec Biol Univ Maternity Children's Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; MYELIN; PLASMALOGEN; VERY LONG CHAIN FATTY ACID;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL FATTY ACID DEFICIENCY; FEMALE; HUMAN; INFANT; LIVER FUNCTION; MALE; METABOLIC DISORDER; MYELINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VISION;

EID: 0031869030     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.26     Document Type: Article

References (34)

1. Goldfischer S, Moore CL, Johnson AB, et al. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 1973;182:62-64.
2. Lazarow PB, Moser HW. Disorders of peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw Hill, 1995:2287-2324.
3. Bowen P, Lee CSM, Zellweger H, Lindenberg R. A familial syndrome of multiple congenital defects. Bull Johns Hopkins Hosp 1964;114:402-414.
4. Jaffe R, Crumrine P, Hashida Y, Moser HW. Neonatal adrenoleukodystrophy: clinical, pathological, and biochemical delineation of a syndrome affecting both males and females. Am J Pathol 1982;108:100-111.
5. Poll-The BT, Saudubray JM, Ogier H, et al. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis 1986;9:169-174.
6. Hajra AK, Bishop JE. Glycerolipid biosynthesis in peroxisomes via de acyl dihydroxyacetone phosphate pathway. Am NY Acad Sci 1982;386:170-182.
7. Keller GA, Barton MC, Shapiro DJ, Singer SJ. 3-Hydroxy-3-methylglutaryl coenzyme A reductase is present in peroxisomes in normal rat liver cells. Proc Natl Acad Sci USA 1985; 82:770-774.
8. Pedersen JI, Kase BF, Prydz K, Björkhem I. Liver peroxisomes and bile acid formation. In: Fahimi HD, Sies H, eds. Peroxisomes in biology and medicine. Berlin: Springer-Verlag, 1987:67-77.
9. Pahan K, Singh I. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes. J Lipid Res 1995;36:986-997.
10. Singh I, Moser AB, Goldfischer S, Moser HW. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci USA 1984;81:4203-4207.
11. Brown FR, McAdams AJ, Cumins JW, et al. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J 1982;151: 344-361.
12. Heymans HSA, Schutgens RBH, Tan R, van den Bosch H, Borst P. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature 1983;306: 69-70.
13. Datta NS, Wilson GN, Hajra AK. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. N Engl J Med 1984;311:1080-1083.
14. Poulos A, Sharp P, Fellenberg AJ, Danks DM. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum Genet 1985;70:172-177.
15. Hanson RF, Szczepanik-van Leeuwen P, Williams GC, Grabowski G, Sharp HL. Defects of bile acids synthesis in Zellweger's syndrome. Science 1979;203:1107-1108.
16. Martinez M. Polyunsaturated fatty acid changes suggesting a new enzymatic defect in Zellweger syndrome. Lipids 1989;24: 261-265.
17. Martinez M. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of D4 desaturation? Neurology 1990;40:1292-1298.
18. Martinez M. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res 1992;583:171-182.
19. Martinez M, Mougan I, Roig M, Ballabriga A. Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study. Lipids 1994;29:273-280.
20. Salem N Jr., Niebylski CD. The nervous system has an absolute molecular species requirement for proper function. Mol Membr Biol 1995;12:131-134.
21. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega-3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986;83:4021-4025.
22. Martinez M, Pineda M, Vidai R, Conill J, and Martin B. Docosahexaenoic acid - a new therapeutic approach to peroxisomal-disorder patients: experience with two cases. Neurology 1993;43:1389-1397.
23. Martinez M. Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications. J Inherit Metab Dis 1995; 18(suppl 1):61-75.
24. Martinez M. Docosahexaenoic acid therapy in DHA-deficient patients with disorders of peroxisomal biogenesis. Lipids 1996;31:S145-152.
25. Christie WW, Brechany EY, Johnson SB, and Holman RT. A comparison of pyrrolidide and picolinyl ester derivatives for the identification of fatty acids in natural samples by gas chromatography-mass spectrometry. Lipids 1986;21:657-661.
26. Barkovich AJ, Lyonn G, Evrard P. Formation, maturation and disorders of white matter. Am J Neuroradiol 1992;13:447-460.
27. Van der Knaap MS, Valk J. Magnetic resonance of myelin, myelination and myelin disorders. 2nd ed. Berlin: Springer-Verlag, 1995.
28. Anderson RE, Benolken RM, Dudley PA, Landis DJ, Wheeler TG. Polyunsaturated fatty acids of photoreceptor membranes. Exp Eye Res 1974;18:205-213.
29. O'Brien JS, Sampson EI. Fatty acid and fatty aldehyde composition of the major lipids in normal human grey matter, white matter and myelin. J Lipid Res 1965;6:545-551.
30. Poduslo SE. The isolation and characterization of a plasma membrane and a myelin fraction derived from oligodendoglia of calf brain. J Neurochem 1975;647-654.
31. Bourre JM, Pascal G, Durand G, Masson M, Sumont O, Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J Neurochem 1984;43:342-348.
32. Voss A, Reinhart M, Sankarappa S, Sprecher H. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 1991;266:19995-20000.
33. Moore SA, Hurt E, Yoder E, Sprecher H, Spector AA. Docosa-hexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. J Lipid Res 1995;36:2433-2443.
34. Infante JP, Huszagh VA. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. Mol Cell Biochem 1997;168:101-115.